Filtered By:
Specialty: Cardiology
Condition: Cardiomyopathy
This page shows you your search results in order of date. This is page number 12.
Order by Relevance | Date
Total 533 results found since Jan 2013.
Non-invasive right ventriculo-arterial coupling as a rehospitalization predictor in dilated cardiomyopathy: A comparison of five different methods
CONCLUSION: RVFW-LS/PASP and RVEF/PASP as non-invasive estimates of RVPAC are independent predictors of HF rehospitalization in patients with DCM.PMID:34939658 | DOI:10.33963/KP.a2021.0190
Source: Kardiologia Polska - December 23, 2021 Category: Cardiology Authors: Aura V îjîiac Vlad B ătăilă Sebastian Onciul Violeta Verinceanu Claudia Guzu Silvia Deaconu Ioana Petre Alina Sc ărlătescu Diana Zamfir Maria Doroban ţu Source Type: research
Long-Term Abnormalities of Lipid Profile After a Single Episode of Sepsis
Conclusions: Our study suggests that persistent derangements of lipid profile components for up to two years after sepsis may be associated with altered risk of atherosclerosis-related events among sepsis survivors.PMID:34869619 | PMC:PMC8634493 | DOI:10.3389/fcvm.2021.674248
Source: Atherosclerosis - December 6, 2021 Category: Cardiology Authors: Nicholas Felici Da Liu Josh Maret Mariana Restrepo Yuliya Borovskiy Jihane Hajj Wesley Chung Krzysztof Laudanski Source Type: research
Promising Nutritional Fruits Against Cardiovascular Diseases: An Overview of Experimental Evidence and Understanding Their Mechanisms of Action
Vasc Health Risk Manag. 2021 Nov 23;17:739-769. doi: 10.2147/VHRM.S328096. eCollection 2021.ABSTRACTCardiovascular diseases (CVDs) are one of the leading causes of morbidity and mortality in both developed and developing countries, affecting millions of individuals each year. Despite the fact that successful therapeutic drugs for the management and treatment of CVDs are available on the market, nutritional fruits appear to offer the greatest benefits to the heart and have been proved to alleviate CVDs. Experimental studies have also demonstrated that nutritional fruits have potential protective effects against CVDs. The ai...
Source: Atherosclerosis - December 3, 2021 Category: Cardiology Authors: Nur Zulaikha Azwa Zuraini Mahendran Sekar Yuan Seng Wu Siew Hua Gan Srinivasa Reddy Bonam Nur Najihah Izzati Mat Rani M Yasmin Begum Pei Teng Lum Vetriselvan Subramaniyan Neeraj Kumar Fuloria Shivkanya Fuloria Source Type: research
Mortality risk in chronic Chagas cardiomyopathy: a systematic review and meta ‐analysis
ConclusionsThe annual mortality risk in chronic Chagas cardiomyopathy is substantial and primarily attributable to cardiovascular causes. This risk significantly increases in patients with low left ventricular ejection fraction and those classified as AHA stages C and C/D.
Source: ESC Heart Failure - November 1, 2021 Category: Cardiology Authors: Sindhu Chadalawada,
Anis Rassi,
Omar Samara,
Anthony Monzon,
Deepika Gudapati,
Lilian Vargas Barahona,
Peter Hyson,
Stefan Sillau,
Luisa Mestroni,
Matthew Taylor,
Maria Consola ção Vieira Moreira,
Kristen DeSanto,
Nelson I. Agudelo Higuita, Tags: Original Research Article Source Type: research
Echocardiographic diagnosis of atrial cardiomyopathy allows outcome prediction following pulmonary vein isolation
ConclusionThe echocardiographic parameters LA-EF and LAS allow accurate, non-invasive diagnosis of ACM and prediction of arrhythmia recurrence after PVI.Graphic abstract
Source: Clinical Research in Cardiology - November 1, 2021 Category: Cardiology Source Type: research
Implantation of ventricular assist devices in hypertrophic cardiomyopathy with left ventricular systolic dysfunction
ConclusionsDespite a decreased right ventricular function with higher BNP values, patients with HCM-LVSD and DCM showed comparable outcomes post-LVAD implantation.
Source: ESC Heart Failure - October 28, 2021 Category: Cardiology Authors: Nobuichiro Yagi,
Osamu Seguchi,
Hiroki Mochizuki,
Kensuke Kuroda,
Seiko Nakajima,
Takuya Watanabe,
Masanobu Yanase,
Naoki Tadokoro,
Satsuki Fukushima,
Tomoyuki Fujita,
Norihide Fukushima Tags: Original Research Article Source Type: research
Low incidence of major complications after the first six hours post atrial fibrillation ablation: Is same ‐day discharge safe and feasible in most patients?
ConclusionAfter AF ablation, very few complications occurred between six hours post-procedure and discharge the next day. Therefore, same-day discharge is a safe option for a majority of patients.This article is protected by copyright. All rights reserved.
Source: Journal of Cardiovascular Electrophysiology - September 18, 2021 Category: Cardiology Authors: Astrid Paul Nordin,
Nikola Drca,
Per Insulander,
Hamid Bastani,
Tara Bourke,
Frieder Braunschweig,
G öran Kennebäck,
Gesa Olshausen,
Bita Sadigh,
Ott Saluveer,
Jari Tapanainen,
Jonas Schwieler,
Finn Åkerström,
Mats Jensen‐Urstad Tags: ORIGINAL ‐ ELECTROPHYSIOLOGY Source Type: research
Anticoagulation in cardiomyopathy: unravelling the hidden threat and challenging the threat individually
AbstractCardiomyopathy comprises a heterogeneous group of myocardial abnormalities, structural or functional in nature, in the absence of coronary artery disease and other abnormal loading conditions. These myocardial pathologies can result in premature death or disability from progressive heart failure, arrhythmia, stroke, or other embolic events. The European Cardiomyopathy Registry reports a high stroke risk in cardiomyopathy patients ranging from 2.1% to 4.5%, as well as high prevalence of atrial fibrillation ranging from 14.0% to 48.5%. There is a growing interest in evaluating the risk of thromboembolism depending on...
Source: ESC Heart Failure - September 9, 2021 Category: Cardiology Authors: Xiaogang Zhu,
Zhenhua Wang,
Markus W. Ferrari,
Katharina Ferrari ‐Kuehne,
Javed Bulter,
Xiuying Xu,
Quanzhong Zhou,
Yuhui Zhang,
Jian Zhang Tags: Review Source Type: research
Sympathetic activation in heart failure with reduced and mildly reduced ejection fraction: the role of aetiology
ConclusionsMuscle sympathetic nerve activity parameters indicated significant sympathetic activation in both HFmrEF and HFrEF patients as compared with healthy controls with no difference in relation to ischaemic versus non-ischaemic aetiology.
Source: ESC Heart Failure - September 7, 2021 Category: Cardiology Authors: R éka Urbancsek,
Zoltán Csanádi,
Ildikó Noémi Forgács,
Tímea Bianka Papp,
Judit Boczán,
Judit Barta,
Csaba Jenei,
László Nagy,
László Rudas Tags: Original Research Article Source Type: research
Clinical significance of new ‐onset atrial fibrillation in patients with hypertrophic cardiomyopathy
ConclusionsIn our HCM registry in an aged Japanese community, a significant proportion developed AF. The presence of AF, particularly new-onset AF, was associated with increased incidence of HCM-related events. AF may not be just a marker of disease stage but an important trigger of adverse events.
Source: ESC Heart Failure - September 2, 2021 Category: Cardiology Authors: Toru Kubo,
Yuichi Baba,
Yuri Ochi,
Takayoshi Hirota,
Naohito Yamasaki,
Kazuya Kawai,
Katsuhito Yamamoto,
Fumiaki Kondo,
Kanji Bando,
Eisuke Yamada,
Takashi Furuno,
Toshikazu Yabe,
Yoshinori L. Doi,
Hiroaki Kitaoka Tags: Original Research Article Source Type: research
Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry
ConclusionDifferences exist in phenotype, recovery of cardiac function and neonatal outcomes according to hypertensive status in women with PPCM.
Source: European Journal of Heart Failure - August 26, 2021 Category: Cardiology Authors: Alice M. Jackson,
Mark C. Petrie,
Alexandra Frogoudaki,
C écile Laroche,
Finn Gustafsson,
Bassem Ibrahim,
Alexandre Mebazaa,
Mark R. Johnson,
Petar M. Seferovic,
Vera Regitz‐Zagrosek,
Amam Mbakwem,
Michael Böhm,
Hawani S. Prameswari,
Doaa Tags: Research Article Source Type: research
